Nanogen, Inc. (Nasdaq: NGEN), developer of molecular and rapid diagnostic products, announced today that it has expanded its partnership with HandyLab, Inc. by signing a licensing and supply agreement for use of the company’s proprietary Minor Groove Binder (MGB) Probe technology and synthetic nucleic acid chemistries, including dyes and quenchers, for use in in vitro […]
New Data Acquisition Software Allows Clinicians and Researchers to Streamline Laboratory Workflow and Enhance Productivity AUSTIN, Texas–Luminex Corporation (NASDAQ: LMNX), the worldwide leader in multiplexed solutions, today announced the commercial release of xPONENT® 3.1 data acquisition software. Launched for use on Luminex 100 and Luminex 200 systems, xPONENT 3.1 includes more than 65 new features […]
Evogen Inc. announced today the appointment of two senior executives to its management team to lead the international commercial business efforts for the newly launched EvoCyclerTM HD12 molecular diagnostics platform. This molecular diagnostics and detection instrument provides innovative ultra-rapid PCR amplification and analysis. Kevin McCormack joins Evogen as Vice President, Sales and Marketing, bringing 20 […]
ROCKVILLE, Md. and EMERYVILLE, Calif., Feb. 24 — Innovative Biosensors, Inc., and ProGenTech Limited, two emerging leaders in life science & diagnostics, today announced an agreement to jointly develop a rapid, integrated diagnostic system. The system will incorporate Innovative Biosensor’s proprietary Cellular Analysis and Notification of Antigen Risks and Yields (“CANARY(R)”) technology, a cell-based approach […]
TUCSON, Ariz. & LENEXA, Kan.–HTG, Inc., provider of the quantitative Nuclease Protection Assay (qNPA™) and service partner for the life sciences industry, and Clinical Reference Laboratory, Inc. (CRL Global Services), provider of testing services for toxicology, molecular diagnostics, clinical trials, bioanalytics, and insurance today announced they signed a multi-year agreement. Under the terms of the […]
MONMOUTH JUNCTION, N.J.–Xenomics, Inc. (PINKSHEETS: XNOM), a developer of non-invasive next-generation molecular diagnostics, announced today that it will begin offering a gender prediction test as a service to expectant mothers who are interested in learning the gender of their baby as early as the 7th week of their pregnancy, much earlier than the availability of […]
Discovery Could Lead to the Development of a Next-Generation Assay to Improve Diagnosis and Treatment of Ovarian Cancer FREMONT, Calif., Feb. 12 — Vermillion, Inc. (OTC Bulletin Board: VRML), a molecular diagnostics company, today announced that the U.S. Patent Office (USPTO) has issued a notice of allowance to the Company for the discovery of hepcidin […]
Accelr8 Technology Corporation (Alternext: AXK) today announced that the company will collaborate with the Denver Health Medical Center (DHMC) in a study of ICU patients at risk for contracting ventilator-associated pneumonia (VAP). Denver Health is receiving funding for the study as a Team Science Award from the Colorado Clinical and Translational Sciences Institute (CCTSI, https://ctsa1.uchsc.edu). […]
BURLINGTON, N.C.–Laboratory Corporation of America® Holdings (LabCorp®) (NYSE:LH) announces that it is the first national clinical laboratory to offer HCV PCR testing using a newly FDA approved assay, the Roche COBAS® AmpliPrep/COBAS® TaqMan® HCV Test. This assay is intended to be used as an aid in managing HCV-infected individuals undergoing antiviral therapy. The assay can […]
HUNTINGTON BEACH, California and AMSTERDAM, The Netherlands, February 11 — Agendia, a world leader in molecular cancer diagnostics, today announced the appointment of Alan B. Carter as the company’s new Vice President of Global Business Development. “As we continue to grow as a global company, Alan’s appointment furthers one of our primary aims,” commented Dr. […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
